{"favorite_id": 2693, "calc_type": "calculator", "dosing": false, "full_title_en": "MELD Score (Original, Pre-2016, Model for End-Stage Liver Disease)", "short_title_en": "MELD Score (Original)", "medium_description_en": "Quantifies end-stage liver disease for transplant planning.", "short_description_en": "Liver transplant planning.", "before_use": "<p>We&rsquo;ve updated and combined our MELD scores into one page. Clinicians can choose the formula that best fits their needs: the original MELD score; the current MELD-Na used by UNOS/OPTN, and the 2022 MELD 3.0 score. <a href=\"https://www.mdcalc.com/calc/10437/model-end-stage-liver-disease-meld?utm_source=site&amp;utm_medium=link&amp;utm_campaign=pre_2016\" target=\"_blank\" rel=\"noopener\">Click here to view</a>.</p>", "instructions_en": "<p>Note: This is the pre-2016 MELD which does not include serum sodium level, as non-US transplant societies are still using the original MELD formula. <calculator id=\"78\">The newer MELD Score is listed as &ldquo;MELD Score&rdquo;</calculator>.</p>", "slug": "meld-score-original-pre-2016-model-end-stage-liver-disease", "logic_language": "javascript", "md5": "3a4e559079b3eec591b752ee1d057e10", "cmeVersion": null, "cmeReleaseDate": null, "cmeEndDate": null, "cmeLastReviewed": null, "publishedAt": "2022-04-21T20:29:11.157Z", "vuid": "99089246-bda4-4e85-bb64-dcc7c9d323f4", "versionNumber": 1, "isVisibleInListView": true, "disabled": false, "replacement_calc_id": null, "disabled_reason": null, "search_abbreviation_en": ["meld", "cirrhosis", "esrd", "hepatitis"], "seo": {"meta_description_en": "The MELD Score (Model For End-Stage Liver Disease) (12 and older) quantifies end-stage liver disease for transplant planning.", "keywords_en": "MELD score, Model For End-Stage Liver Disease, Model For End-Stage Liver, Model For End-Stage, Model For End-Stage Liver Disease adult, Model For End-Stage Liver Disease 12 and up, meld score adult, meld model, meld calc, meld score 12, meld liver disease, meld prognosis, meld mortality, ESLD calc, ESLD score, ESLD model, ESLD prognosis, ESLD mortaltiy, ESLD criteria, original, pre-2016"}, "content": {"reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}, "how_to_use": {"use_case_en": "<p>Determines prognosis and prioritizes receipt of liver transplantation.</p>", "pearls_pitfalls_en": "<ul>\n<li>The <calculator id=\"78\">MELD</calculator> was updated in January 2016 and now includes serum sodium level.</li>\n<li>It is preferable to using the calculator to calculate the MELD as there are several caveats relating to minimum and maximum values assigned in the MELD.</li>\n<li>Values should be no more than 48 hours old.</li>\n</ul>", "why_use_en": "<p>MELD is the standard used by the Organ Procurement and Transplantation Network (OPTN) and determines who is the highest priority to receive liver transplants in the US.</p>"}, "next_steps": {"advice_en": "<p>The MELD score helps to estimate prognosis for patients with end-stage liver disease, and is used to prioritize transplant recipients.</p>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p>Original MELD Score = (0.957 * ln(Serum Cr) + 0.378 * ln(Serum Bilirubin) + 1.120 * ln(INR) + 0.643 ) * 10 (if hemodialysis, value for Creatinine is automatically set to 4.0)</p>\n<p>Note: If any score is &lt;1, the MELD assumes the score is equal to 1.</p>\n<p>This is the pre-2016 MELD which does not include serum sodium level, as non-US transplant societies are still using the original MELD formula. See the <calculator id=\"78\">newer MELD formula here.</calculator></p>", "more_info_en": "", "evidence_based_medicine_en": "", "references_list": {"Validation": [{"text": "Wiesner R, United Network for Organ Sharing Liver Disease Severity Score Committee, et al. Model for end-stage liver disease (MELD) and allocation of donor livers.Gastroenterology. 2003 Jan;124(1):91-6.", "href": "https://www.ncbi.nlm.nih.gov/pubmed/12512033"}], "Outcomes": [], "Validations": [], "Original/Primary Reference": [{"text": "Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001 Feb;33(2):464-70.", "href": "https://www.ncbi.nlm.nih.gov/pubmed/11172350"}], "Other References": [{"text": "Kremers WK, van IJperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, Wiesner RH. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients.Hepatology. 2004 Mar;39(3):764-9.", "href": "https://www.ncbi.nlm.nih.gov/pubmed/14999695"}, {"text": "Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD).Hepatology. 2007 Mar;45(3):797-805.", "href": "https://www.ncbi.nlm.nih.gov/pubmed/17326206"}], "Clinical Practice Guidelines": [], "Manufacturer Website": []}}, "creator": [{"qa_en": "", "approved": null, "name": "Dr. Patrick S. Kamath", "creator_info": {"deceased": null, "about_en": "<p>Patrick S. Kamath, MD, is a professor of gastroenterology and hepatology at the Mayo Clinic in Rochester, Minnesota. His research interests include acute-on-chronic liver failure, nonalcoholic fatty liver disease, polycystic liver disease, Budd-Chiari syndrome and hereditary hemorrhagic telangiectasia. Dr. Kamath is internationally renowned as a leading researcher in hepatology and has also won numerous awards as an educator.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-patrick-s-kamath.jpeg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Kamath%20PS%5BAuthor%5D"}}], "contributor": {"expert_name": []}}, "input_schema": [{"type": "toggle", "name": "dialysis", "conditionality": null, "optional": false, "default": null, "label_en": "Dialysis at least twice in the past week", "show_points": false, "tips_en": "", "option_fhir_rules": null, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "md_calc_info_concept": null}, {"conditionality": null, "tips_en": "", "optional": false, "name": "creatinine", "type": "textbox", "label_en": "Creatinine", "default": null, "inct": null, "unit": "cr", "fhir_rules": null, "unit_info": {"name": "Creatinine", "conversion": 88.4, "error_min": 0.01, "error_max": 40, "warn_min": 0, "warn_max": 10, "normal_max_si": 115, "normal_min_si": 62, "normal_min_us": 0.7, "units_si": "\u00b5mol/L", "units_us": "mg/dL", "normal_max_us": 1.3}}, {"conditionality": null, "tips_en": "", "optional": false, "name": "bilirubin", "type": "textbox", "label_en": "Bilirubin", "default": null, "inct": null, "unit": "bili", "fhir_rules": null, "unit_info": {"name": "Bilirubin", "conversion": 17.104, "error_min": 1e-08, "error_max": 50, "warn_min": 0, "warn_max": 20, "normal_max_si": 32.49, "normal_min_si": 5.13, "normal_min_us": 0.3, "units_si": "\u00b5mol/L", "units_us": "mg/dL", "normal_max_us": 1.9}}, {"conditionality": null, "tips_en": "", "optional": false, "name": "inr", "type": "textbox", "label_en": "INR", "default": null, "inct": null, "unit": "inr", "fhir_rules": null, "unit_info": {"name": "INR", "conversion": 1, "error_min": 0.1, "error_max": 20, "warn_min": 0.5, "warn_max": 10, "normal_max_si": 1.2, "normal_min_si": 0.8, "normal_min_us": 0.8, "units_si": " ", "units_us": " ", "normal_max_us": 1.2}}], "chief_complaint_en": ["Abdominal Pain"], "specialty_en": ["Critical Care", "Gastroenterology", "Hepatology", "Hospitalist Medicine", "Internal Medicine", "Nephrology", "Surgery (General)"], "purpose_en": ["Prognosis", "Treatment"], "system_en": ["Gastrointestinal"], "disease_en": ["Cirrhosis", "Hepatitis"], "tags": [], "versions": [], "related_calcs": [{"calcId": 78, "short_title_en": "MELD Na (UNOS/OPTN)", "slug": "meld-score-model-end-stage-liver-disease-12-older"}, {"calcId": 87, "short_title_en": "PELD Score", "slug": "peld-score-pediatric-end-stage-liver-disease-younger-12"}, {"calcId": 2024, "short_title_en": "Lille Model", "slug": "lille-model-alcoholic-hepatitis"}]}